These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide. Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Jaroscak J; Goltry K; Smith A; Waters-Pick B; Martin PL; Driscoll TA; Howrey R; Chao N; Douville J; Burhop S; Fu P; Kurtzberg J Blood; 2003 Jun; 101(12):5061-7. PubMed ID: 12595310 [TBL] [Abstract][Full Text] [Related]
9. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162 [TBL] [Abstract][Full Text] [Related]
10. Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. Stiff PJ; Montesinos P; Peled T; Landau E; Goudsmid NR; Mandel J; Hasson N; Olesinski E; Glukhman E; Snyder DA; Cohen EG; Kidron OS; Bracha D; Harati D; Ben-Abu K; Freind E; Freedman LS; Cohen YC; Olmer L; Barishev R; Rocha V; Gluckman E; Horowitz MM; Eapen M; Nagler A; Sanz G Biol Blood Marrow Transplant; 2018 Jul; 24(7):1463-1470. PubMed ID: 29477778 [TBL] [Abstract][Full Text] [Related]
11. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. de Lima M; McNiece I; Robinson SN; Munsell M; Eapen M; Horowitz M; Alousi A; Saliba R; McMannis JD; Kaur I; Kebriaei P; Parmar S; Popat U; Hosing C; Champlin R; Bollard C; Molldrem JJ; Jones RB; Nieto Y; Andersson BS; Shah N; Oran B; Cooper LJ; Worth L; Qazilbash MH; Korbling M; Rondon G; Ciurea S; Bosque D; Maewal I; Simmons PJ; Shpall EJ N Engl J Med; 2012 Dec; 367(24):2305-15. PubMed ID: 23234514 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329 [TBL] [Abstract][Full Text] [Related]
13. Low rate of infusional toxicity after expanded cord blood transplantation. Bear AS; Hanley PJ; Bosque DM; Cruz CR; Kaur I; Liu H; Kebriaei P; Hosing C; Rezvani K; Oran B; De Lima MJ; Bollard CM; Shpall EJ Cytotherapy; 2014 Aug; 16(8):1153-7. PubMed ID: 24582458 [TBL] [Abstract][Full Text] [Related]
14. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. McNiece IK; Almeida-Porada G; Shpall EJ; Zanjani E Exp Hematol; 2002 Jun; 30(6):612-6. PubMed ID: 12063029 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768 [TBL] [Abstract][Full Text] [Related]
16. Increased expansion and differentiation of cord blood products using a two-step expansion culture. McNiece I; Kubegov D; Kerzic P; Shpall EJ; Gross S Exp Hematol; 2000 Oct; 28(10):1181-6. PubMed ID: 11027837 [TBL] [Abstract][Full Text] [Related]
17. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Magro E; Regidor C; Cabrera R; Sanjuán I; Forès R; Garcia-Marco JA; Ruiz E; Gil S; Bautista G; Millán I; Madrigal A; Fernandez MN Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070 [TBL] [Abstract][Full Text] [Related]
18. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Peled T; Landau E; Prus E; Treves AJ; Nagler A; Fibach E Br J Haematol; 2002 Mar; 116(3):655-61. PubMed ID: 11849228 [TBL] [Abstract][Full Text] [Related]
19. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860 [TBL] [Abstract][Full Text] [Related]